{"news_desk": "Business", "print_page": "", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By REUTERS", "person": [], "organization": "REUTERS"}, "abstract": null, "type_of_material": "Brief", "word_count": "128", "lead_paragraph": "Synergy Pharmaceuticals said its drug to treat idiopathic constipation met the main goal in a late-stage trial, sending its shares up as much as 67 percent to a four-year high.", "pub_date": "2015-06-18T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Constipation Drug Succeeds in Late-Stage Trial", "content_kicker": "Business briefing", "print_headline": "Constipation Drug Succeeds In Late-Stage Trial "}, "snippet": "Synergy Pharmaceuticals said its drug to treat idiopathic constipation met the main goal in a late-stage trial, sending its shares up as much as 67 percent to a four-year high.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/06/18/business/constipation-drug-succeeds-in-late-stage-trial.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Constipation", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Synergy Pharmaceuticals Inc", "name": "organizations"}], "blog": [], "_id": "558203c638f0d837d1b0b1ad", "source": "The New York Times"}